Logo image of CURI

CURIOSITYSTREAM INC (CURI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CURI - US23130Q1076 - Common Stock

3.7 USD
+0.09 (+2.49%)
Last: 1/16/2026, 8:03:23 PM
3.7 USD
0 (0%)
After Hours: 1/16/2026, 8:03:23 PM
Fundamental Rating

4

Taking everything into account, CURI scores 4 out of 10 in our fundamental rating. CURI was compared to 80 industry peers in the Entertainment industry. The financial health of CURI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CURI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CURI has reported negative net income.
  • In the past year CURI had a positive cash flow from operations.
  • In the past 5 years CURI always reported negative net income.
  • In the past 5 years CURI reported 4 times negative operating cash flow.
CURI Yearly Net Income VS EBIT VS OCF VS FCFCURI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -7.30%, CURI is not doing good in the industry: 66.25% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -11.56%, CURI is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
ROA -7.3%
ROE -11.56%
ROIC N/A
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
CURI Yearly ROA, ROE, ROICCURI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • CURI has a better Gross Margin (54.50%) than 61.25% of its industry peers.
  • CURI's Gross Margin has been stable in the last couple of years.
  • CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
CURI Yearly Profit, Operating, Gross MarginsCURI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

  • CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CURI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CURI has been increased compared to 5 years ago.
  • CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CURI Yearly Shares OutstandingCURI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CURI Yearly Total Debt VS Total AssetsCURI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -0.75, we must say that CURI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CURI (-0.75) is worse than 68.75% of its industry peers.
  • There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -0.75
ROIC/WACCN/A
WACC10.34%
CURI Yearly LT Debt VS Equity VS FCFCURI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that CURI should not have too much problems paying its short term obligations.
  • CURI's Current ratio of 1.62 is fine compared to the rest of the industry. CURI outperforms 71.25% of its industry peers.
  • CURI has a Quick Ratio of 1.62. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.62, CURI is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
CURI Yearly Current Assets VS Current LiabilitesCURI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

  • CURI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.86%, which is quite impressive.
  • Looking at the last year, CURI shows a very strong growth in Revenue. The Revenue has grown by 28.62%.
  • CURI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.47% yearly.
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)28.62%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.66%

3.2 Future

  • Based on estimates for the next years, CURI will show a very strong growth in Earnings Per Share. The EPS will grow by 50.40% on average per year.
  • Based on estimates for the next years, CURI will show a quite strong growth in Revenue. The Revenue will grow by 13.02% on average per year.
EPS Next Y74.5%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
EPS Next 5Y50.4%
Revenue Next Year41.59%
Revenue Next 2Y23.63%
Revenue Next 3Y21.34%
Revenue Next 5Y13.02%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CURI Yearly Revenue VS EstimatesCURI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
CURI Yearly EPS VS EstimatesCURI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CURI. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 181.37 indicates a quite expensive valuation of CURI.
  • CURI's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CURI to the average of the S&P500 Index (24.26), we can say CURI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 181.37
CURI Price Earnings VS Forward Price EarningsCURI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CURI is valued a bit cheaper than the industry average as 61.25% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CURI indicates a rather cheap valuation: CURI is cheaper than 88.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.91
EV/EBITDA 21.32
CURI Per share dataCURI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as CURI's earnings are expected to grow with 36.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.4%
EPS Next 3Y36.66%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 9.36%, CURI is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 8.69, CURI pays a better dividend. On top of this CURI pays more dividend than 95.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CURI pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.36%

5.2 History

  • CURI is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CURI Yearly Dividends per shareCURI Yearly Dividends per shareYearly Dividends per share 2024 2025 0.1 0.2 0.3

5.3 Sustainability

  • The earnings of CURI are negative and hence is the payout ratio. CURI will probably not be able to sustain this dividend level.
DP-342.83%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
CURI Yearly Income VS Free CF VS DividendCURI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

CURIOSITYSTREAM INC

NASDAQ:CURI (1/16/2026, 8:03:23 PM)

After market: 3.7 0 (0%)

3.7

+0.09 (+2.49%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-12
Earnings (Next)03-09
Inst Owners33.27%
Inst Owner Change-1.09%
Ins Owners7.76%
Ins Owner Change1.59%
Market Cap215.71M
Revenue(TTM)66.59M
Net Income(TTM)-5.45M
Analysts86
Price Target6.63 (79.19%)
Short Float %4.86%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 9.36%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-342.83%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.44%
Min Revenue beat(2)9.49%
Max Revenue beat(2)13.4%
Revenue beat(4)3
Avg Revenue beat(4)6.66%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)13.4%
Revenue beat(8)3
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)-2.28%
Revenue beat(16)8
Avg Revenue beat(16)-1.46%
PT rev (1m)0%
PT rev (3m)3.38%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-84.62%
EPS NY rev (3m)-300%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 181.37
P/S 3.24
P/FCF 17.91
P/OCF 17.79
P/B 4.57
P/tB 11.29
EV/EBITDA 21.32
EPS(TTM)-0.09
EYN/A
EPS(NY)0.02
Fwd EY0.55%
FCF(TTM)0.21
FCFY5.58%
OCF(TTM)0.21
OCFY5.62%
SpS1.14
BVpS0.81
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.3%
ROE -11.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.5%
FCFM 18.09%
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0.5%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion 152.89%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z -0.75
F-Score7
WACC10.34%
ROIC/WACCN/A
Cap/Depr(3y)0.12%
Cap/Depr(5y)1.04%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y74.5%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
EPS Next 5Y50.4%
Revenue 1Y (TTM)28.62%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.66%
Revenue Next Year41.59%
Revenue Next 2Y23.63%
Revenue Next 3Y21.34%
Revenue Next 5Y13.02%
EBIT growth 1Y43.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.9%
EBIT Next 3Y51.92%
EBIT Next 5Y26.01%
FCF growth 1Y153.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y154.1%
OCF growth 3YN/A
OCF growth 5YN/A

CURIOSITYSTREAM INC / CURI FAQ

What is the fundamental rating for CURI stock?

ChartMill assigns a fundamental rating of 4 / 10 to CURI.


What is the valuation status for CURI stock?

ChartMill assigns a valuation rating of 3 / 10 to CURIOSITYSTREAM INC (CURI). This can be considered as Overvalued.


Can you provide the profitability details for CURIOSITYSTREAM INC?

CURIOSITYSTREAM INC (CURI) has a profitability rating of 1 / 10.


How sustainable is the dividend of CURIOSITYSTREAM INC (CURI) stock?

The dividend rating of CURIOSITYSTREAM INC (CURI) is 4 / 10 and the dividend payout ratio is -342.83%.